Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

DB:08HH Stock Report

Market Cap: €8.3b

Shanghai Fosun Pharmaceutical (Group) Future Growth

Future criteria checks 4/6

Shanghai Fosun Pharmaceutical (Group) is forecast to grow earnings and revenue by 30.1% and 7.9% per annum respectively. EPS is expected to grow by 30.4% per annum. Return on equity is forecast to be 8.7% in 3 years.

Key information

30.1%

Earnings growth rate

30.4%

EPS growth rate

Pharmaceuticals earnings growth21.5%
Revenue growth rate7.9%
Future return on equity8.7%
Analyst coverage

Good

Last updated01 Nov 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:08HH - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202649,2024,368N/A5,9765
12/31/202546,3923,663N/A5,3986
12/31/202441,6122,808N/A3,7252
9/30/202441,6112,114-2073,939N/A
6/30/202440,4671,835-9763,511N/A
3/31/202440,6862,009-1,4303,458N/A
12/31/202341,4002,386-1,9223,414N/A
9/30/202343,0293,578-2,0953,535N/A
6/30/202343,9993,972-2,0074,229N/A
3/31/202344,4374,261-1,8584,235N/A
12/31/202243,9523,731-1,6714,218N/A
9/30/202243,5863,600-1,8824,066N/A
6/30/202243,4063,782-1,2524,030N/A
3/31/202241,3404,338-1,1404,057N/A
12/31/202139,0114,729-1,0353,938N/A
9/30/202135,2534,749-1,5253,142N/A
6/30/202133,2314,430-1,9942,825N/A
3/31/202132,4833,933-1,7482,934N/A
12/31/202030,3073,663-1,8572,580N/A
9/30/202029,4603,737-1,0213,347N/A
6/30/202028,4413,520-5923,234N/A
3/31/202027,7363,187-5523,197N/A
12/31/201928,5853,322-7403,222N/A
9/30/201928,0042,677-4493,191N/A
6/30/201927,2322,664-8933,122N/A
3/31/201925,9292,714-8752,892N/A
12/31/201824,9182,708-2252,950N/A
9/30/201823,7162,799-552,945N/A
6/30/201822,0402,996N/A2,755N/A
3/31/201820,3723,092N/A2,644N/A
12/31/201718,5343,124N/A2,580N/A
9/30/201716,9513,047N/A2,310N/A
6/30/201716,0452,993N/A2,278N/A
3/31/201715,2832,908N/A2,128N/A
12/31/201614,6292,805N/A2,110N/A
9/30/201614,1732,745N/A1,983N/A
6/30/201613,6242,657N/A1,880N/A
3/31/201613,0342,557N/A1,822N/A
12/31/201512,6092,459N/A1,621N/A
9/30/201512,4382,429N/A1,519N/A
6/30/201512,4082,398N/A1,474N/A
3/31/201512,1682,234N/A1,376N/A
12/31/201412,0262,113N/A1,200N/A
9/30/201411,5872,207N/A1,388N/A
6/30/201411,0261,987N/A1,104N/A
3/31/201410,5981,646N/A942N/A
12/31/20139,9961,583N/A1,012N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 08HH's forecast earnings growth (30.1% per year) is above the savings rate (1%).

Earnings vs Market: 08HH's earnings (30.1% per year) are forecast to grow faster than the German market (20.9% per year).

High Growth Earnings: 08HH's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 08HH's revenue (7.9% per year) is forecast to grow faster than the German market (5.6% per year).

High Growth Revenue: 08HH's revenue (7.9% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 08HH's Return on Equity is forecast to be low in 3 years time (8.7%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y